Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017
170413_Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017
Top 10 Spec Stocks 2017
170320_Top 13 Speculative Stocks March 2017
Dr Richard Mollard appointed as Chief Scientific Officer of PharmAust
170308_Dr Richard Mollard appointed as Chief Scientific Officer of PharmAust
PharmAust raises a further $534K
170303_PHARMAUST RAISES A FURTHER $534k
Dr Richard Hopkins Appointed as CEO of PharmAust
170301_Dr Richard Hopkins Appointed as CEO of PharmAust
Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016
170131_Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016
PharmAust receives $406K R&D rebate from ATO
170130_PHARMAUST RECEIVES $406K R&D REBATE FROM ATO